サンプル依頼リスト カート
  • English
  • Korean
デフォルト表紙
市場調査レポート
商品コード
1795259

リガーゼ酵素の世界市場

Ligases Enzyme

出版日
ページ情報
英文 183 Pages
納期
即日から翌営業日
適宜更新あり
価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=148.28円
リガーゼ酵素の世界市場
出版日: 2025年08月21日
発行: Global Industry Analysts, Inc.
ページ情報: 英文 183 Pages
納期: 即日から翌営業日
GIIご利用のメリット
  • 全表示
  • 概要
  • 目次
概要

リガーゼ酵素の世界市場は2030年までに127億米ドルに達する

2024年に79億米ドルと推定されるリガーゼ酵素の世界市場は、分析期間2024-2030年にCAGR 8.2%で成長し、2030年には127億米ドルに達すると予測されます。本レポートで分析したセグメントの1つである微生物ソースは、CAGR 6.8%を記録し、分析期間終了時には62億米ドルに達すると予測されます。動物源セグメントの成長率は、分析期間でCAGR 9.8%と推定されます。

米国市場は22億米ドルと推定、中国はCAGR12.5%で成長予測

米国のリガーゼ酵素市場は2024年に22億米ドルと推定されます。世界第2位の経済大国である中国は、分析期間2024-2030年のCAGR12.5％を引きずる形で、2030年までに27億米ドルの市場規模に達すると予測されています。その他の注目すべき地域別市場としては、日本とカナダがあり、分析期間中のCAGRはそれぞれ4.2%と7.8%と予測されています。欧州では、ドイツがCAGR 5.4%で成長すると予測されています。

世界のリガーゼ酵素市場- 主要動向と促進要因のまとめ

リガーゼ酵素は、分子診断と遺伝子工学の進歩においてどのように重要な役割を果たすようになったか？

分子生物学の重要な担い手であるリガーゼ酵素は、特に遺伝子工学と診断の領域において、多くの科学的・産業的応用の中心的役割を担っています。これらの酵素は、しばしばDNAやRNA鎖の間に新たな化学結合を形成することによって、2つの大きな分子の結合を触媒し、遺伝物質の操作や組み立てに不可欠なものとなっています。組換えDNA技術、クローニング、ゲノム配列決定においてその利用が拡大していることは、現代のバイオテクノロジーにおけるその基礎的役割を浮き彫りにしています。分子診断学では、リガーゼ酵素は、点突然変異や病原体を高感度で検出する強力な方法であるリガーゼ連鎖反応（LCR）を含む、ライゲーションに基づくアッセイに不可欠です。遺伝性疾患、感染症、がんの有病率が世界的に上昇を続ける中、正確で効率的な診断ツール（その多くはリガーゼ活性に依存している）の需要が急増しています。この動向は、早期発見、個別化医療、精密診断の必要性によって強化されており、これらにはすべて強固で精密な分子ツールが必要です。さらに、リガーゼはポイント・オブ・ケア診断キットにますます組み込まれ、リアルタイムの分散型検査ソリューションを提供しています。この変化は、迅速で信頼性の高い結果が患者の転帰を著しく改善する、資源が限られた環境において特に大きな影響を与えます。

リガーゼのイノベーションを推進する上で、研究機関やバイオ製薬会社はどのような役割を果たしているか？

バイオテクノロジーと製薬部門は、活発な研究開発（R&D）イニシアティブに支えられ、リガーゼに基づく技術の革新を主導しています。学術機関は、しばしば営利企業と共同で、新規リガーゼの発見や、様々な基質や環境条件下での性能を向上させるための既存リガーゼのエンジニアリングの最前線に立っています。過酷な条件下でも機能する耐熱性リガーゼが改良され続けることで、その応用範囲は従来の研究室環境以外にも広がっています。特にCRISPRを介した遺伝子編集では、リガーゼが高い特異性で二本鎖DNA切断の修復を助ける。このようなアプリケーションでは、超高忠実度とオフターゲット効果の最小化が要求されるため、カスタマイズされたリガーゼの必要性が高まっています。さらに、特に合成ゲノム、代謝経路構築、無細胞システムなどの分野における合成生物学への投資の増加は、リガーゼ酵素市場をさらに強固なものにしています。これらの酵素は、特にDNA/RNAプラットフォームに基づく次世代ワクチンの開発における可能性についても研究されています。リガーゼを取り巻く技術革新のエコシステムは、公的・私的資金、特許活動、新規ライゲーション技術の知的財産権確保に対する公開会社の戦略的関心によって支えられています。

産業バイオテクノロジーが非医療分野におけるリガーゼの需要をどのように促進しているか？

リガーゼ酵素は医学や学術研究の枠を超え、産業バイオテクノロジー、特に農業、環境、食品分野で大きな足跡を残しています。農業分野では、害虫に抵抗したり、除草剤に耐えたり、栄養価を高めたりするように設計された遺伝子組み換え作物（GMO）の開発にリガーゼが使われています。遺伝子組換えにおけるリガーゼの精度と効率は、安定した遺伝子組換え系統を作り出すための理想的なツールとなっています。環境バイオテクノロジーもまた新たな分野であり、リガーゼはバイオレメディエーションや持続可能な廃棄物処理のための微生物工学の一翼を担っています。メタゲノム解析における酵素の役割は、研究者が微生物群集とその機能をよりよく理解することを可能にし、汚染物質の分解や資源のリサイクルを目的とした合成生物の設計に役立ちます。一方、食品産業では、リガーゼは発酵、酵素生産、食品添加物の合成に使用される遺伝子改良株の開発に貢献しています。クリーンラベルのバイオテクノロジーに基づくソリューションが消費者に支持されるにつれ、非遺伝子組み換えの酵素製造やタンパク質工学におけるリガーゼの利用もそれに応じて拡大しています。これらの産業用途では、リガーゼが耐久性のある忠実度の高い分子結合を形成する能力を持つため、安定したスケーラブルなバイオプロセスが可能になるという利点があります。その結果、これらの分野の企業は、生産性の向上と環境負荷の低減を目指し、リガーゼベースのシステムの採用を加速させています。

リガーゼ酵素市場拡大の原動力は？

リガーゼ酵素市場の成長は、バイオテクノロジー、ヘルスケア、工業分野の進化するニーズに深く根ざしたいくつかの要因によって牽引されています。ゲノム配列決定や合成生物学における技術の進歩により、複雑でハイスループットな環境で作動する高効率で特殊なリガーゼの需要が高まっています。個別化医療、特に腫瘍学や希少遺伝子疾患の急増は、正確で個別化された遺伝学的洞察を提供するライゲーションベースの診断ツールへの依存度を高めています。遺伝子編集のためのCRISPR-Casシステムの利用拡大により、リガーゼがDNAの正確な修復を促進し、市場拡大に大きく寄与しています。消費者側では、遺伝的健康に対する意識の高まりと家庭用DNA検査キットの利用可能性の拡大が、これらのプラットフォームに組み込まれた酵素ツールに対する需要を加速させています。さらに、有利な政府政策とバイオベース経済への世界的関心に支えられたバイオテクノロジー新興企業への資金提供の増加が、リガーゼ中心技術の革新と商業的採用に拍車をかけています。産業用途では、持続可能で環境に配慮したプロセスの推進により、バイオ製造や農業工学におけるリガーゼの利用が拡大しています。最後に、主要酵素メーカーがポートフォリオの多様化と地域市場への浸透、特にアジア太平洋とラテンアメリカに戦略的な重点を置いていることが、リガーゼ酵素市場の成長軌道をさらに後押ししています。

セグメント

供給源（微生物供給源、動物供給源、植物供給源）

調査対象企業の例

  • Agilent Technologies
  • ArcticZymes Technologies ASA
  • Becton, Dickinson and Company（BD）
  • BioVision Inc.
  • Creative Enzymes
  • Cytiva（Danaher Corporation）
  • Enzo Life Sciences
  • F. Hoffmann-La Roche AG
  • GenScript
  • Illumina Inc.
  • LGC Biosearch Technologies
  • Merck KGaA
  • New England Biolabs
  • Oxford Nanopore Technologies
  • Promega Corporation
  • QIAGEN N.V.
  • R&D Systems, Inc.
  • Takara Bio Inc.
  • Thermo Fisher Scientific Inc.
  • Zymo Research
  • BASF SE

AIインテグレーション

検証された専門家コンテンツとAIツールにより、市場情報と競合情報を変革します。

Global Industry Analystsは、一般的なLLMや業界別SLMのクエリに従う代わりに、ビデオ記録、ブログ、検索エンジン調査、大量の企業、製品/サービス、市場データなど、世界中の専門家から収集したコンテンツのリポジトリを構築しました。

関税影響係数

Global Industry Analystsは、本社の国、製造拠点、輸出入（完成品とOEM）に基づく企業の競争力の変化を予測しています。この複雑で多面的な市場力学は、売上原価（COGS）の増加、収益性の低下、サプライチェーンの再構築など、ミクロおよびマクロの市場力学の中でも特に競合他社に影響を与える見込みです。

目次

第1章 調査手法

第2章 エグゼクティブサマリー

  • 市場概要
  • 主要企業
  • 市場動向と促進要因
  • 世界市場の見通し

第3章 市場分析

  • 米国
  • カナダ
  • 日本
  • 中国
  • 欧州
  • フランス
  • ドイツ
  • イタリア
  • 英国
  • スペイン
  • ロシア
  • その他欧州
  • アジア太平洋
  • オーストラリア
  • インド
  • 韓国
  • その他アジア太平洋地域
  • ラテンアメリカ
  • アルゼンチン
  • ブラジル
  • メキシコ
  • その他ラテンアメリカ
  • 中東
  • イラン
  • イスラエル
  • サウジアラビア
  • アラブ首長国連邦
  • その他中東
  • アフリカ

第4章 競合

目次
Product Code: MCP37280

Global Ligases Enzyme Market to Reach US$12.7 Billion by 2030

The global market for Ligases Enzyme estimated at US$7.9 Billion in the year 2024, is expected to reach US$12.7 Billion by 2030, growing at a CAGR of 8.2% over the analysis period 2024-2030. Microorganism Source, one of the segments analyzed in the report, is expected to record a 6.8% CAGR and reach US$6.2 Billion by the end of the analysis period. Growth in the Animal Source segment is estimated at 9.8% CAGR over the analysis period.

The U.S. Market is Estimated at US$2.2 Billion While China is Forecast to Grow at 12.5% CAGR

The Ligases Enzyme market in the U.S. is estimated at US$2.2 Billion in the year 2024. China, the world's second largest economy, is forecast to reach a projected market size of US$2.7 Billion by the year 2030 trailing a CAGR of 12.5% over the analysis period 2024-2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at a CAGR of 4.2% and 7.8% respectively over the analysis period. Within Europe, Germany is forecast to grow at approximately 5.4% CAGR.

Global Ligases Enzyme Market - Key Trends & Drivers Summarized

How Are Ligases Enzymes Becoming Pivotal in Advancing Molecular Diagnostics and Genetic Engineering?

Ligases enzymes, critical players in molecular biology, have taken center stage in a multitude of scientific and industrial applications, especially within the realm of genetic engineering and diagnostics. These enzymes catalyze the joining of two large molecules by forming a new chemical bond, often between DNA or RNA strands, making them indispensable in the manipulation and assembly of genetic material. Their growing use in recombinant DNA technologies, cloning, and genome sequencing highlights their foundational role in modern biotechnology. In molecular diagnostics, ligases enzymes are essential for ligation-based assays, including Ligase Chain Reaction (LCR), which is a powerful method for detecting point mutations and pathogens with high sensitivity. As the prevalence of genetic disorders, infectious diseases, and cancer continues to rise globally, the demand for accurate and efficient diagnostic tools-many of which rely on ligase activity-has surged. This trend is reinforced by the need for early detection, personalized medicine, and precision diagnostics, all of which require robust and precise molecular tools. Furthermore, ligases are increasingly integrated into point-of-care diagnostic kits, offering real-time, decentralized testing solutions. This shift is especially impactful in resource-limited settings, where fast and reliable results can significantly improve patient outcomes.

What Role Do Research Institutions and Biopharmaceutical Companies Play in Propelling Ligases Innovation?

The biotechnology and pharmaceutical sectors are leading the charge in innovating ligases-based technologies, backed by vigorous research and development (R&D) initiatives. Academic institutions, often in collaboration with commercial enterprises, are at the forefront of discovering novel ligases and engineering existing ones to improve their performance across various substrates and environmental conditions. The continued refinement of thermostable ligases, capable of functioning under extreme conditions, has expanded their applicability beyond traditional laboratory environments. Major biopharma companies are increasingly adopting ligase enzymes in their drug discovery and gene therapy pipelines, notably in CRISPR-mediated gene editing, where ligases help repair double-strand DNA breaks with high specificity. These applications demand ultra-high fidelity and minimal off-target effects, reinforcing the necessity for customized ligases. Additionally, increased investment in synthetic biology-particularly in areas like synthetic genomes, metabolic pathway construction, and cell-free systems-has further solidified the market for ligases enzymes. These enzymes are also being studied for their potential in the development of next-generation vaccines, especially those based on DNA/RNA platforms. The ecosystem of innovation surrounding ligases is underpinned by public and private funding, patent activity, and the strategic interest of companies in securing intellectual property rights for novel ligation techniques.

How Is Industrial Biotechnology Fueling the Demand for Ligases in Non-Medical Sectors?

Beyond medical and academic research, ligases enzymes are carving out a significant footprint in industrial biotechnology, notably in agricultural, environmental, and food sectors. In agriculture, ligases are employed in the development of genetically modified organisms (GMOs) designed to resist pests, tolerate herbicides, or exhibit enhanced nutritional profiles. The precision and efficiency of ligases in gene assembly make them ideal tools for creating stable transgenic lines. Environmental biotechnology is another emerging arena, where ligases play a role in engineering microbes for bio-remediation and sustainable waste processing. The enzyme’s role in metagenomic analysis allows researchers to better understand microbial communities and their functions, aiding in the design of synthetic organisms tailored to degrade pollutants or recycle resources. Meanwhile, in the food industry, ligases contribute to the development of genetically improved strains used in fermentation, enzyme production, and the synthesis of food additives. As clean-label, biotech-based solutions gain favor with consumers, the utilization of ligases in non-GMO enzyme manufacturing and protein engineering grows accordingly. These industrial uses benefit from ligases’ ability to form durable, high-fidelity molecular bonds, enabling stable and scalable bioprocesses. Consequently, companies in these sectors are ramping up their adoption of ligase-based systems to increase productivity and reduce environmental impact.

What Is Powering the Momentum Behind the Expanding Ligases Enzyme Market?

The growth in the ligases enzyme market is driven by several factors deeply rooted in the evolving needs of biotechnology, healthcare, and industrial sectors. Technological advancements in genomic sequencing and synthetic biology have escalated the demand for highly efficient and specialized ligases that can operate in complex and high-throughput environments. The surge in personalized medicine, especially in oncology and rare genetic disorders, has increased the dependency on ligation-based diagnostic tools that deliver precise and individualized genetic insights. The expanding use of CRISPR-Cas systems for gene editing, where ligases facilitate accurate DNA repairs, has significantly contributed to market expansion. On the consumer side, the heightened awareness of genetic health and growing availability of at-home DNA testing kits is accelerating demand for the enzymatic tools embedded in these platforms. Additionally, increased funding for biotechnology startups, supported by favorable government policies and global interest in bio-based economies, is spurring innovation and commercial adoption of ligase-centric technologies. In industrial applications, the drive for sustainable and environmentally responsible processes has led to broader usage of ligases in biomanufacturing and agricultural engineering. Finally, the strategic focus of major enzyme producers on portfolio diversification and regional market penetration, particularly in Asia-Pacific and Latin America, is further fueling the growth trajectory of the ligases enzyme market.

SCOPE OF STUDY:

The report analyzes the Ligases Enzyme market in terms of units by the following Segments, and Geographic Regions/Countries:

Segments:

Source (Microorganism Source, Animal Source, Plant Source)

Geographic Regions/Countries:

World; United States; Canada; Japan; China; Europe (France; Germany; Italy; United Kingdom; Spain; Russia; and Rest of Europe); Asia-Pacific (Australia; India; South Korea; and Rest of Asia-Pacific); Latin America (Argentina; Brazil; Mexico; and Rest of Latin America); Middle East (Iran; Israel; Saudi Arabia; United Arab Emirates; and Rest of Middle East); and Africa.

Select Competitors (Total 42 Featured) -

  • Agilent Technologies
  • ArcticZymes Technologies ASA
  • Becton, Dickinson and Company (BD)
  • BioVision Inc.
  • Creative Enzymes
  • Cytiva (Danaher Corporation)
  • Enzo Life Sciences
  • F. Hoffmann-La Roche AG
  • GenScript
  • Illumina Inc.
  • LGC Biosearch Technologies
  • Merck KGaA
  • New England Biolabs
  • Oxford Nanopore Technologies
  • Promega Corporation
  • QIAGEN N.V.
  • R&D Systems, Inc.
  • Takara Bio Inc.
  • Thermo Fisher Scientific Inc.
  • Zymo Research
  • BASF SE

AI INTEGRATIONS

We're transforming market and competitive intelligence with validated expert content and AI tools.

Instead of following the general norm of querying LLMs and Industry-specific SLMs, we built repositories of content curated from domain experts worldwide including video transcripts, blogs, search engines research, and massive amounts of enterprise, product/service, and market data.

TARIFF IMPACT FACTOR

Our new release incorporates impact of tariffs on geographical markets as we predict a shift in competitiveness of companies based on HQ country, manufacturing base, exports and imports (finished goods and OEM). This intricate and multifaceted market reality will impact competitors by increasing the Cost of Goods Sold (COGS), reducing profitability, reconfiguring supply chains, amongst other micro and macro market dynamics.

TABLE OF CONTENTS

I. METHODOLOGY

II. EXECUTIVE SUMMARY

  • 1. MARKET OVERVIEW
    • Influencer Market Insights
    • World Market Trajectories
    • Tariff Impact on Global Supply Chain Patterns
    • Ligases Enzyme - Global Key Competitors Percentage Market Share in 2025 (E)
    • Competitive Market Presence - Strong/Active/Niche/Trivial for Players Worldwide in 2025 (E)
  • 2. FOCUS ON SELECT PLAYERS
  • 3. MARKET TRENDS & DRIVERS
    • Growth in Genomics and DNA Repair Research Throws the Spotlight on Ligases as Essential Molecular Tools
    • Surge in NGS and PCR-Based Applications Propels Demand for High-Fidelity DNA Ligases
    • Advancements in Molecular Cloning and Synthetic Biology Strengthen Business Case for Specialized Ligase Enzymes
    • Rising Focus on Precision Medicine and Biomarker Discovery Fuels Use of Ligases in Diagnostic Assays
    • Expansion of CRISPR and Gene Editing Platforms Generates Demand for Ligase-Compatible Enzyme Kits
    • Product Innovation in Thermostable and ATP-Independent Ligases Enhances Workflow Efficiency
    • Development of Point-of-Care and Isothermal Amplification Methods Drives Need for Rapid Ligation Enzymes
    • Increased Investment in Life Sciences R&D Globally Supports Ligase Enzyme Market Growth
    • Demand for Ligase Enzymes in DNA Library Preparation Throws the Spotlight on High-Throughput Sequencing Workflows
    • Rising Awareness of DNA Damage Repair Mechanisms Spurs Use of Ligases in Cancer Research and Drug Development
    • Growth of Biopharmaceutical Manufacturing Expands Application of Ligases in Quality Control and QC Assays
    • Evolving Enzyme Formulation and Stabilization Techniques Enable Longer Shelf Life and Broader Storage Flexibility
  • 4. GLOBAL MARKET PERSPECTIVE
    • TABLE 1: World Ligases Enzyme Market Analysis of Annual Sales in US$ Million for Years 2014 through 2030
    • TABLE 2: World Recent Past, Current & Future Analysis for Ligases Enzyme by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 3: World Historic Review for Ligases Enzyme by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 4: World 16-Year Perspective for Ligases Enzyme by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets for Years 2014, 2025 & 2030
    • TABLE 5: World Recent Past, Current & Future Analysis for Microorganism Source by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 6: World Historic Review for Microorganism Source by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 7: World 16-Year Perspective for Microorganism Source by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2025 & 2030
    • TABLE 8: World Recent Past, Current & Future Analysis for Animal Source by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 9: World Historic Review for Animal Source by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 10: World 16-Year Perspective for Animal Source by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2025 & 2030
    • TABLE 11: World Recent Past, Current & Future Analysis for Plant Source by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 12: World Historic Review for Plant Source by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 13: World 16-Year Perspective for Plant Source by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2025 & 2030

III. MARKET ANALYSIS

  • UNITED STATES
    • Ligases Enzyme Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United States for 2025 (E)
    • TABLE 14: USA Recent Past, Current & Future Analysis for Ligases Enzyme by Source - Microorganism Source, Animal Source and Plant Source - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 15: USA Historic Review for Ligases Enzyme by Source - Microorganism Source, Animal Source and Plant Source Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 16: USA 16-Year Perspective for Ligases Enzyme by Source - Percentage Breakdown of Value Sales for Microorganism Source, Animal Source and Plant Source for the Years 2014, 2025 & 2030
  • CANADA
    • TABLE 17: Canada Recent Past, Current & Future Analysis for Ligases Enzyme by Source - Microorganism Source, Animal Source and Plant Source - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 18: Canada Historic Review for Ligases Enzyme by Source - Microorganism Source, Animal Source and Plant Source Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 19: Canada 16-Year Perspective for Ligases Enzyme by Source - Percentage Breakdown of Value Sales for Microorganism Source, Animal Source and Plant Source for the Years 2014, 2025 & 2030
  • JAPAN
    • Ligases Enzyme Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Japan for 2025 (E)
    • TABLE 20: Japan Recent Past, Current & Future Analysis for Ligases Enzyme by Source - Microorganism Source, Animal Source and Plant Source - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 21: Japan Historic Review for Ligases Enzyme by Source - Microorganism Source, Animal Source and Plant Source Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 22: Japan 16-Year Perspective for Ligases Enzyme by Source - Percentage Breakdown of Value Sales for Microorganism Source, Animal Source and Plant Source for the Years 2014, 2025 & 2030
  • CHINA
    • Ligases Enzyme Market Presence - Strong/Active/Niche/Trivial - Key Competitors in China for 2025 (E)
    • TABLE 23: China Recent Past, Current & Future Analysis for Ligases Enzyme by Source - Microorganism Source, Animal Source and Plant Source - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 24: China Historic Review for Ligases Enzyme by Source - Microorganism Source, Animal Source and Plant Source Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 25: China 16-Year Perspective for Ligases Enzyme by Source - Percentage Breakdown of Value Sales for Microorganism Source, Animal Source and Plant Source for the Years 2014, 2025 & 2030
  • EUROPE
    • Ligases Enzyme Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Europe for 2025 (E)
    • TABLE 26: Europe Recent Past, Current & Future Analysis for Ligases Enzyme by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 27: Europe Historic Review for Ligases Enzyme by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 28: Europe 16-Year Perspective for Ligases Enzyme by Geographic Region - Percentage Breakdown of Value Sales for France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets for Years 2014, 2025 & 2030
    • TABLE 29: Europe Recent Past, Current & Future Analysis for Ligases Enzyme by Source - Microorganism Source, Animal Source and Plant Source - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 30: Europe Historic Review for Ligases Enzyme by Source - Microorganism Source, Animal Source and Plant Source Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 31: Europe 16-Year Perspective for Ligases Enzyme by Source - Percentage Breakdown of Value Sales for Microorganism Source, Animal Source and Plant Source for the Years 2014, 2025 & 2030
  • FRANCE
    • Ligases Enzyme Market Presence - Strong/Active/Niche/Trivial - Key Competitors in France for 2025 (E)
    • TABLE 32: France Recent Past, Current & Future Analysis for Ligases Enzyme by Source - Microorganism Source, Animal Source and Plant Source - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 33: France Historic Review for Ligases Enzyme by Source - Microorganism Source, Animal Source and Plant Source Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 34: France 16-Year Perspective for Ligases Enzyme by Source - Percentage Breakdown of Value Sales for Microorganism Source, Animal Source and Plant Source for the Years 2014, 2025 & 2030
  • GERMANY
    • Ligases Enzyme Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Germany for 2025 (E)
    • TABLE 35: Germany Recent Past, Current & Future Analysis for Ligases Enzyme by Source - Microorganism Source, Animal Source and Plant Source - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 36: Germany Historic Review for Ligases Enzyme by Source - Microorganism Source, Animal Source and Plant Source Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 37: Germany 16-Year Perspective for Ligases Enzyme by Source - Percentage Breakdown of Value Sales for Microorganism Source, Animal Source and Plant Source for the Years 2014, 2025 & 2030
  • ITALY
    • TABLE 38: Italy Recent Past, Current & Future Analysis for Ligases Enzyme by Source - Microorganism Source, Animal Source and Plant Source - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 39: Italy Historic Review for Ligases Enzyme by Source - Microorganism Source, Animal Source and Plant Source Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 40: Italy 16-Year Perspective for Ligases Enzyme by Source - Percentage Breakdown of Value Sales for Microorganism Source, Animal Source and Plant Source for the Years 2014, 2025 & 2030
  • UNITED KINGDOM
    • Ligases Enzyme Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United Kingdom for 2025 (E)
    • TABLE 41: UK Recent Past, Current & Future Analysis for Ligases Enzyme by Source - Microorganism Source, Animal Source and Plant Source - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 42: UK Historic Review for Ligases Enzyme by Source - Microorganism Source, Animal Source and Plant Source Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 43: UK 16-Year Perspective for Ligases Enzyme by Source - Percentage Breakdown of Value Sales for Microorganism Source, Animal Source and Plant Source for the Years 2014, 2025 & 2030
  • SPAIN
    • TABLE 44: Spain Recent Past, Current & Future Analysis for Ligases Enzyme by Source - Microorganism Source, Animal Source and Plant Source - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 45: Spain Historic Review for Ligases Enzyme by Source - Microorganism Source, Animal Source and Plant Source Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 46: Spain 16-Year Perspective for Ligases Enzyme by Source - Percentage Breakdown of Value Sales for Microorganism Source, Animal Source and Plant Source for the Years 2014, 2025 & 2030
  • RUSSIA
    • TABLE 47: Russia Recent Past, Current & Future Analysis for Ligases Enzyme by Source - Microorganism Source, Animal Source and Plant Source - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 48: Russia Historic Review for Ligases Enzyme by Source - Microorganism Source, Animal Source and Plant Source Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 49: Russia 16-Year Perspective for Ligases Enzyme by Source - Percentage Breakdown of Value Sales for Microorganism Source, Animal Source and Plant Source for the Years 2014, 2025 & 2030
  • REST OF EUROPE
    • TABLE 50: Rest of Europe Recent Past, Current & Future Analysis for Ligases Enzyme by Source - Microorganism Source, Animal Source and Plant Source - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 51: Rest of Europe Historic Review for Ligases Enzyme by Source - Microorganism Source, Animal Source and Plant Source Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 52: Rest of Europe 16-Year Perspective for Ligases Enzyme by Source - Percentage Breakdown of Value Sales for Microorganism Source, Animal Source and Plant Source for the Years 2014, 2025 & 2030
  • ASIA-PACIFIC
    • Ligases Enzyme Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Asia-Pacific for 2025 (E)
    • TABLE 53: Asia-Pacific Recent Past, Current & Future Analysis for Ligases Enzyme by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 54: Asia-Pacific Historic Review for Ligases Enzyme by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 55: Asia-Pacific 16-Year Perspective for Ligases Enzyme by Geographic Region - Percentage Breakdown of Value Sales for Australia, India, South Korea and Rest of Asia-Pacific Markets for Years 2014, 2025 & 2030
    • TABLE 56: Asia-Pacific Recent Past, Current & Future Analysis for Ligases Enzyme by Source - Microorganism Source, Animal Source and Plant Source - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 57: Asia-Pacific Historic Review for Ligases Enzyme by Source - Microorganism Source, Animal Source and Plant Source Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 58: Asia-Pacific 16-Year Perspective for Ligases Enzyme by Source - Percentage Breakdown of Value Sales for Microorganism Source, Animal Source and Plant Source for the Years 2014, 2025 & 2030
  • AUSTRALIA
    • Ligases Enzyme Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Australia for 2025 (E)
    • TABLE 59: Australia Recent Past, Current & Future Analysis for Ligases Enzyme by Source - Microorganism Source, Animal Source and Plant Source - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 60: Australia Historic Review for Ligases Enzyme by Source - Microorganism Source, Animal Source and Plant Source Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 61: Australia 16-Year Perspective for Ligases Enzyme by Source - Percentage Breakdown of Value Sales for Microorganism Source, Animal Source and Plant Source for the Years 2014, 2025 & 2030
  • INDIA
    • Ligases Enzyme Market Presence - Strong/Active/Niche/Trivial - Key Competitors in India for 2025 (E)
    • TABLE 62: India Recent Past, Current & Future Analysis for Ligases Enzyme by Source - Microorganism Source, Animal Source and Plant Source - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 63: India Historic Review for Ligases Enzyme by Source - Microorganism Source, Animal Source and Plant Source Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 64: India 16-Year Perspective for Ligases Enzyme by Source - Percentage Breakdown of Value Sales for Microorganism Source, Animal Source and Plant Source for the Years 2014, 2025 & 2030
  • SOUTH KOREA
    • TABLE 65: South Korea Recent Past, Current & Future Analysis for Ligases Enzyme by Source - Microorganism Source, Animal Source and Plant Source - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 66: South Korea Historic Review for Ligases Enzyme by Source - Microorganism Source, Animal Source and Plant Source Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 67: South Korea 16-Year Perspective for Ligases Enzyme by Source - Percentage Breakdown of Value Sales for Microorganism Source, Animal Source and Plant Source for the Years 2014, 2025 & 2030
  • REST OF ASIA-PACIFIC
    • TABLE 68: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Ligases Enzyme by Source - Microorganism Source, Animal Source and Plant Source - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 69: Rest of Asia-Pacific Historic Review for Ligases Enzyme by Source - Microorganism Source, Animal Source and Plant Source Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 70: Rest of Asia-Pacific 16-Year Perspective for Ligases Enzyme by Source - Percentage Breakdown of Value Sales for Microorganism Source, Animal Source and Plant Source for the Years 2014, 2025 & 2030
  • LATIN AMERICA
    • Ligases Enzyme Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Latin America for 2025 (E)
    • TABLE 71: Latin America Recent Past, Current & Future Analysis for Ligases Enzyme by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 72: Latin America Historic Review for Ligases Enzyme by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 73: Latin America 16-Year Perspective for Ligases Enzyme by Geographic Region - Percentage Breakdown of Value Sales for Argentina, Brazil, Mexico and Rest of Latin America Markets for Years 2014, 2025 & 2030
    • TABLE 74: Latin America Recent Past, Current & Future Analysis for Ligases Enzyme by Source - Microorganism Source, Animal Source and Plant Source - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 75: Latin America Historic Review for Ligases Enzyme by Source - Microorganism Source, Animal Source and Plant Source Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 76: Latin America 16-Year Perspective for Ligases Enzyme by Source - Percentage Breakdown of Value Sales for Microorganism Source, Animal Source and Plant Source for the Years 2014, 2025 & 2030
  • ARGENTINA
    • TABLE 77: Argentina Recent Past, Current & Future Analysis for Ligases Enzyme by Source - Microorganism Source, Animal Source and Plant Source - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 78: Argentina Historic Review for Ligases Enzyme by Source - Microorganism Source, Animal Source and Plant Source Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 79: Argentina 16-Year Perspective for Ligases Enzyme by Source - Percentage Breakdown of Value Sales for Microorganism Source, Animal Source and Plant Source for the Years 2014, 2025 & 2030
  • BRAZIL
    • TABLE 80: Brazil Recent Past, Current & Future Analysis for Ligases Enzyme by Source - Microorganism Source, Animal Source and Plant Source - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 81: Brazil Historic Review for Ligases Enzyme by Source - Microorganism Source, Animal Source and Plant Source Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 82: Brazil 16-Year Perspective for Ligases Enzyme by Source - Percentage Breakdown of Value Sales for Microorganism Source, Animal Source and Plant Source for the Years 2014, 2025 & 2030
  • MEXICO
    • TABLE 83: Mexico Recent Past, Current & Future Analysis for Ligases Enzyme by Source - Microorganism Source, Animal Source and Plant Source - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 84: Mexico Historic Review for Ligases Enzyme by Source - Microorganism Source, Animal Source and Plant Source Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 85: Mexico 16-Year Perspective for Ligases Enzyme by Source - Percentage Breakdown of Value Sales for Microorganism Source, Animal Source and Plant Source for the Years 2014, 2025 & 2030
  • REST OF LATIN AMERICA
    • TABLE 86: Rest of Latin America Recent Past, Current & Future Analysis for Ligases Enzyme by Source - Microorganism Source, Animal Source and Plant Source - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 87: Rest of Latin America Historic Review for Ligases Enzyme by Source - Microorganism Source, Animal Source and Plant Source Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 88: Rest of Latin America 16-Year Perspective for Ligases Enzyme by Source - Percentage Breakdown of Value Sales for Microorganism Source, Animal Source and Plant Source for the Years 2014, 2025 & 2030
  • MIDDLE EAST
    • Ligases Enzyme Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Middle East for 2025 (E)
    • TABLE 89: Middle East Recent Past, Current & Future Analysis for Ligases Enzyme by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 90: Middle East Historic Review for Ligases Enzyme by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 91: Middle East 16-Year Perspective for Ligases Enzyme by Geographic Region - Percentage Breakdown of Value Sales for Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets for Years 2014, 2025 & 2030
    • TABLE 92: Middle East Recent Past, Current & Future Analysis for Ligases Enzyme by Source - Microorganism Source, Animal Source and Plant Source - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 93: Middle East Historic Review for Ligases Enzyme by Source - Microorganism Source, Animal Source and Plant Source Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 94: Middle East 16-Year Perspective for Ligases Enzyme by Source - Percentage Breakdown of Value Sales for Microorganism Source, Animal Source and Plant Source for the Years 2014, 2025 & 2030
  • IRAN
    • TABLE 95: Iran Recent Past, Current & Future Analysis for Ligases Enzyme by Source - Microorganism Source, Animal Source and Plant Source - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 96: Iran Historic Review for Ligases Enzyme by Source - Microorganism Source, Animal Source and Plant Source Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 97: Iran 16-Year Perspective for Ligases Enzyme by Source - Percentage Breakdown of Value Sales for Microorganism Source, Animal Source and Plant Source for the Years 2014, 2025 & 2030
  • ISRAEL
    • TABLE 98: Israel Recent Past, Current & Future Analysis for Ligases Enzyme by Source - Microorganism Source, Animal Source and Plant Source - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 99: Israel Historic Review for Ligases Enzyme by Source - Microorganism Source, Animal Source and Plant Source Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 100: Israel 16-Year Perspective for Ligases Enzyme by Source - Percentage Breakdown of Value Sales for Microorganism Source, Animal Source and Plant Source for the Years 2014, 2025 & 2030
  • SAUDI ARABIA
    • TABLE 101: Saudi Arabia Recent Past, Current & Future Analysis for Ligases Enzyme by Source - Microorganism Source, Animal Source and Plant Source - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 102: Saudi Arabia Historic Review for Ligases Enzyme by Source - Microorganism Source, Animal Source and Plant Source Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 103: Saudi Arabia 16-Year Perspective for Ligases Enzyme by Source - Percentage Breakdown of Value Sales for Microorganism Source, Animal Source and Plant Source for the Years 2014, 2025 & 2030
  • UNITED ARAB EMIRATES
    • TABLE 104: UAE Recent Past, Current & Future Analysis for Ligases Enzyme by Source - Microorganism Source, Animal Source and Plant Source - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 105: UAE Historic Review for Ligases Enzyme by Source - Microorganism Source, Animal Source and Plant Source Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 106: UAE 16-Year Perspective for Ligases Enzyme by Source - Percentage Breakdown of Value Sales for Microorganism Source, Animal Source and Plant Source for the Years 2014, 2025 & 2030
  • REST OF MIDDLE EAST
    • TABLE 107: Rest of Middle East Recent Past, Current & Future Analysis for Ligases Enzyme by Source - Microorganism Source, Animal Source and Plant Source - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 108: Rest of Middle East Historic Review for Ligases Enzyme by Source - Microorganism Source, Animal Source and Plant Source Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 109: Rest of Middle East 16-Year Perspective for Ligases Enzyme by Source - Percentage Breakdown of Value Sales for Microorganism Source, Animal Source and Plant Source for the Years 2014, 2025 & 2030
  • AFRICA
    • Ligases Enzyme Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Africa for 2025 (E)
    • TABLE 110: Africa Recent Past, Current & Future Analysis for Ligases Enzyme by Source - Microorganism Source, Animal Source and Plant Source - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 111: Africa Historic Review for Ligases Enzyme by Source - Microorganism Source, Animal Source and Plant Source Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 112: Africa 16-Year Perspective for Ligases Enzyme by Source - Percentage Breakdown of Value Sales for Microorganism Source, Animal Source and Plant Source for the Years 2014, 2025 & 2030

IV. COMPETITION